| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/22/2007 | CN101020044A Regulating and controlling effect of thymine DNA glycosylase on signal transducing path |
| 08/22/2007 | CN101020034A Prepn process of medicine for treating cerebral apoplexy and its sequela |
| 08/22/2007 | CN101020022A Sleep improving health product |
| 08/22/2007 | CN101020007A Medicine composition for treating college entrance examination syndrome and its use |
| 08/22/2007 | CN101020005A Oral medicine for treating dizziness and its prepn |
| 08/22/2007 | CN101020004A Migraine treating Chinese medicine |
| 08/22/2007 | CN101019992A Combined plaster for treating insomnia |
| 08/22/2007 | CN101019980A Health product for improving sleep quality |
| 08/22/2007 | CN101019977A Health product for improving sleep quality |
| 08/22/2007 | CN101019957A Habit-breaking candy and its prepn |
| 08/22/2007 | CN101019933A Chinese medicine composition and its prepn process |
| 08/22/2007 | CN101019889A Prepn process of brain protein hydrolysate injection |
| 08/22/2007 | CN101019879A Compound coenzyme Q10 medicine prepn and its prepn process and application |
| 08/22/2007 | CN101019877A Soluble mangiferin clathrate and its prepn |
| 08/22/2007 | CN101019871A Emerine salicylate oral liquid and its prepn |
| 08/22/2007 | CN101019870A New use of sarsasapogenin in medicine for preventing and treating depression |
| 08/22/2007 | CN101019867A Trandsermal plaster prepn of buprenorphine hydrochloride |
| 08/22/2007 | CN101019844A Transdermal plaster prepn of Tramadol hydrochloride |
| 08/22/2007 | CN101019842A Application of curcumin in preparing medicine for treating IIIV-1 relevant cognitive disorder |
| 08/22/2007 | CN101019649A Health product for improving sleep |
| 08/22/2007 | CN101019627A Micro jet and instantaneous high pressure process of preparing whole lily powder |
| 08/21/2007 | US7259232 Preferred segments of neural thread protein |
| 08/21/2007 | US7259170 Macrolides containing pharmaceutical compositions |
| 08/21/2007 | US7259165 especially 3-sulfonylpyrazolo[4.3b]pyridines and 3-sulfonylpyrrolo[3.2b] and [2.3b]pyridines; treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor, such as attention deficit disorder; obsessive compulsive disorder; and withdrawal from drug, alcohol or nicotine |
| 08/21/2007 | US7259162 Benzazole derivatives and their use as JNK modulators |
| 08/21/2007 | US7259161 For therapy of immune response, an autoimmune disease, a neurodegenerative, or a solid or hematologic malignancy |
| 08/21/2007 | US7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists |
| 08/21/2007 | US7259148 Hepatoprotective activity of 2′-p-hydroxybenzoylmussaenosidic acid |
| 08/21/2007 | US7259015 Vector system |
| 08/21/2007 | US7258872 Chromone enteric release formulation |
| 08/21/2007 | US7258871 Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states |
| 08/21/2007 | US7258859 Method for the treatment of multiple sclerosis |
| 08/21/2007 | US7258855 Culturing a transformant in a medium, allowing the polypeptide having phospholipase a2 activity fo form and accumulating in the culture, recovering the polypeptide thus formed |
| 08/21/2007 | CA2493885C Use of sodium channel blocking compounds and aspirin in manufacturing drugs for producing synergistically analgesic effect in mammals |
| 08/21/2007 | CA2443285C Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
| 08/21/2007 | CA2379445C Lactams substituted by cyclic succinates as inhibitors of a.beta. protein production |
| 08/21/2007 | CA2315827C Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 08/21/2007 | CA2304965C ((cyclo)alkyl substituted)-gamma-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders |
| 08/17/2007 | CA2579188A1 Treatment of amyloid-related diseases |
| 08/16/2007 | WO2007092469A2 Combination of organic compounds |
| 08/16/2007 | WO2007092458A1 Antidotes to exogenous neurotoxic agents |
| 08/16/2007 | WO2007092400A1 Aminophenyl derivatives as selective androgen receptor modulators |
| 08/16/2007 | WO2007092391A1 Androgen receptor modulators and methods of treating disease using the same |
| 08/16/2007 | WO2007092334A1 Method of treating sleep disorders |
| 08/16/2007 | WO2007092333A1 Use of olopatadine for treating sleep disorders |
| 08/16/2007 | WO2007091948A2 Novel spiro [imidazolidine-4, 3´-indole] 2, 2´,5´(1h) triones for treatment of conditions associated with vanilloid receptor 1 |
| 08/16/2007 | WO2007091947A2 Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1'h)-triones for treatment of conditions associated with vanilloid receptor 1 |
| 08/16/2007 | WO2007091946A1 Use of spiro [ imidazolidine-4, 3'-indole] 2, 2', 5' (1h) triones for treatment of conditions associated with vanilloid receptor 1 |
| 08/16/2007 | WO2007091613A1 Prophylactic or therapeutic agent for alzheimer's disease, and food/beverage |
| 08/16/2007 | WO2007091570A1 Binding inhibitor of sphingosine-1-phosphate |
| 08/16/2007 | WO2007091396A1 Novel amidopropionic acid derivative and pharmaceutical product containing same |
| 08/16/2007 | WO2007091250A2 Enzyme replacement therapy for treating lysosomal storage diseases |
| 08/16/2007 | WO2007091018A1 Non-natural amino acid derivatives |
| 08/16/2007 | WO2007091017A1 Amino acid derivatives |
| 08/16/2007 | WO2007090923A1 Process for manufacturing entacapone |
| 08/16/2007 | WO2007090913A1 Use of pi3k activity agonist compounds in the production of pharmaceutical compositions, the resulting pharmaceutical compositions and applications thereof in the treatment of diseases |
| 08/16/2007 | WO2007090888A1 3-heteroaryl- 3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists |
| 08/16/2007 | WO2007090886A1 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/16/2007 | WO2007090841A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 08/16/2007 | WO2007090840A1 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia |
| 08/16/2007 | WO2007090720A2 Use of 2-imidazoles for the treatment of cns disorders |
| 08/16/2007 | WO2007090617A2 Thiadiazole derivatives for the treatment of neuro degenerative diseases |
| 08/16/2007 | WO2007090409A1 Use of kcnq-openers for threating or reducing the symptoms of schizophrenia |
| 08/16/2007 | WO2007075834A3 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of epilepsy |
| 08/16/2007 | WO2007075698A3 Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents |
| 08/16/2007 | WO2007072497A3 Stabilized pharmaceutical composition of pramipexole and method of preparation thereof |
| 08/16/2007 | WO2007026959A3 Derivatives of 4-piperazin-1-yl-4-benz0 [b] thiophene suitable for the treatment of cns disorders |
| 08/16/2007 | WO2007016208A3 1,2-benzisoxazole-3-methane-sulfonic acid ammonium salt |
| 08/16/2007 | WO2007008562A3 Carbamate compounds for use in treating neurodegenerative disorders |
| 08/16/2007 | WO2007007919A3 Heterocyclic janus kinase 3 inhibitors |
| 08/16/2007 | WO2006124753A3 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
| 08/16/2007 | WO2006079637A8 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders |
| 08/16/2007 | WO2004091609A3 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit |
| 08/16/2007 | WO2004007437A9 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 08/16/2007 | US20070192034 Methods for representing sequence-dependent contextual information present in polymer sequence and uses thereof |
| 08/16/2007 | US20070191592 amidated peptide; stress-related conditions |
| 08/16/2007 | US20070191468 Amino alcohol compound |
| 08/16/2007 | US20070191457 Compounds having activity at 5ht2c receptor and uses thereof |
| 08/16/2007 | US20070191435 Hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 08/16/2007 | US20070191422 Nicotinic acetylcholine receptor ligands |
| 08/16/2007 | US20070191419 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning |
| 08/16/2007 | US20070191417 Quinoline 3-amino chroman derivatives |
| 08/16/2007 | US20070191412 Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor |
| 08/16/2007 | US20070191386 Bicyclo-pyrazole compounds specially pyrrolo[3,4-c]pyrazole or tetrahydropyridine[4,3-c]pyrazole derivatives; anticarcinogenic agents; N-{5-phenylacetyl-4,6-dihydropyrrolo[3,4-c]pyrazol-3-yl}phenylacetamide; modulators of apoptosis; combinatorial chemical library with an isocyanate polystyrenic resin |
| 08/16/2007 | US20070191352 Prophylaxis, therapy of Alzheimer's disease, Pick's disease; administering phenothiazine compound such as methylene blue |
| 08/16/2007 | US20070191347 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 08/16/2007 | US20070191330 Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
| 08/16/2007 | US20070191328 Isoquinoline compounds |
| 08/16/2007 | US20070191311 P2x receptor inhibitor |
| 08/16/2007 | US20070191310 Antiinflammatory agents; antiischemic agents; antiarthritic agents; antihistamines; multiple sclerosis; Alzheimer's disease; Huntington's disease; parkinson's disease; antiepileptic agents; 1-Stearoyl-2-{3-[2-(2,6-dichloroanilino)phenylacetamido]propanoyl}-sn-glycero-3-phosphocholine |
| 08/16/2007 | US20070191308 Intranasal formulation of rotigotine |
| 08/16/2007 | US20070191289 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 08/16/2007 | US20070191274 Active hedgehog protein conjugate |
| 08/16/2007 | US20070191267 Use of tyrosine kinase inhibitors for treating cerebral ischemia |
| 08/16/2007 | US20070190612 31 Human Secreted Proteins |
| 08/16/2007 | US20070190117 Buccal formulations of galanthamine and uses thereof |
| 08/16/2007 | US20070190106 Phosphorus-containing compounds & uses thereof |
| 08/16/2007 | US20070190076 A bacterial preparation consisting of freeze dried, non-denatured Mycobacterium bovis and water, in an amount effective to stimulate leukocytic regulatory cells, used for the prevention and/or the treatment of cancer, autoimmune diseases, allergies and tuberculosis; vaccines |
| 08/16/2007 | US20070190054 Prevention and treatment of complement-associated disorders |
| 08/16/2007 | US20070190043 decreasing or inhabiting hyperproliferation of keratinocytes and/or T-cells ; cream; use treating psoriasis or atopic dermatitis for example |